1)  Tissue-specifi c peptide pool
					 
	
					
				
				 
	
					
				组织特异性肽池
			
					2)  tissue polypeptide specific antigen
					 
	
					
				
				 
	
					
				组织多肽特异性抗原
				1.
					Monitoring of tissue polypeptide specific antigen in the treatment for advanced cancers and its significance;
						
						组织多肽特异性抗原检测在中晚期肿瘤治疗中的意义
					2.
					Clinical value of tissue polypeptide specific antigen;
					 
					
						
						 
					
						组织多肽特异性抗原的临床意义
					3.
					Objective To study the clinical value of combined detection of 4 tumor markers, namely lactic dehydrogenate (LDH), tissue polypeptide specific antigen (TPS), carcinoembryonic antigen (CEA) and 32-microglobulin (β2-MG) in patients with non-Hodgkin s lymphoma (NHL).
						
						目的探讨在非霍奇金淋巴瘤(NHL)患者中,血清乳酸脱氢酶(LDH)、组织多肽特异性抗原(TPS)、癌胚抗原(CEA) 和β2-微球蛋白(β2-MG)这4项指标测定的临床意义。
					
					3)  tissue polypeptide specific antigen(TPS)
					 
	
					
				
				 
	
					
				组织多肽特异性抗原
				1.
					Objective: To investigate the expression of tissue polypeptide specific antigen(TPS),cytokeratin 19 fragment(CYFRA21-1)and squamous cell carcinoma antigen(SCC-Ag) in patients with lung cancer and the clinical value to the diagnosis of lung cancer.
						
						目的:探讨组织多肽特异性抗原(tissue polypeptide specific antigen,TPS)、细胞角蛋白19(cytokeratin19 fragment,CYFRA21-1)和鳞状细胞癌抗原(SCC-Ag)在肺癌患者血清中的表达水平及其对肺癌诊断的临床应用价值。
					
					4)  Urine tissue polypeptide specific antigen
					 
	
					
				
				 
	
					
				尿组织多肽特异性抗原
				1.
					Urine tissue polypeptide specific antigen level and its application in the diagnosis of bladder transitional cell cancer;
						
						尿组织多肽特异性抗原水平诊断膀胱移行细胞癌的意义
					
					5)  TPS
					 
	
					
				
				 
	
					
				组织多肽特异性抗原
				1.
					EVALUATION OF CLINICAL VALUE OF TISSUE POLYPEPTIDE SPECIFIC ANTIGEN (TPS)ASSAY IN GASTRO-INTESTINAL   CARCINOMAS;
						
						组织多肽特异性抗原在胃肠道肿瘤中的临床应用价值
					2.
					To study diagnostic value of simultaneous detection of three markers,tumor markers tissue polypeptide specific antigen(TPS),neuro-specific enolase(CYFRA21-1)and carcino embryonic antigen(CEA) in patients with lung cancer.
						
						目的:探讨组织多肽特异性抗原(TPS)、细胞角蛋白19片段(CYFRA21-1)和癌胚抗原(CEA)三项标志物联合检测对非小细胞肺癌的诊断价值。
					
					6)  tissue polypeptide-specific antigen
					 
	
					
				
				 
	
					
				组织多肽特异性抗原
				1.
					[Purpose] To investigate the clinical significance of serum tissue polypeptide-specific antigen (TPS), neuron-specific enolase (NSE) and carcinoembryonic antigen (CEA) in diagnosis, monitoring and prognosis for small cell lung cancer (SCLC).
						
						[目的]探讨小细胞肺癌(SCLC)患者血清中组织多肽特异性抗原(TPS)、神经元特异烯醇化酶(NSE)和癌胚抗原(CEA)水平对SCLC临床诊断、病情监测及预后判断的临床意义。
					补充资料:周期性特异性药物
		周期性特异性药物
仅能杀灭*细胞增殖周期中某一期癌细胞的抗癌药物。依其作用又分为两类:①作用于S期药物,如*羟基脲、*阿糖胞苷,甲氨蝶呤、巯基嘌呤、硫鸟嘌呤等。其中前两种药物特异性较高,主要干扰DNA合成,但因也能干扰 RNA的合成,可能起到一定的自限作用。临床上宜缓慢静滴或肌注给药。②作用于M期的药物,如长春新碱等。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
	参考词条